Reuters, "Strattera to carry suicide warning for children"
The Food and Drug Administration Thursday advised doctors and care givers to monitor children and adolescents being treated with Eli Lilly and Co.’s Strattera drug for attention-deficit/hyperactivity disorder. Earlier Thursday, Lilly said it would add strong warnings, including the risk of suicidal thoughts, to its label for Strattera. Strattera will now carry a “black box” warning, the strongest required by regulators.Lilly said there were no suicides among children, adolescents or adults taking the medication during Strattera clinical trials, but there was one suicide attempt in a patient taking the drug.